307 related articles for article (PubMed ID: 10790203)
1. RET and GDNF gene scanning in Hirschsprung patients using two dual denaturing gel systems.
Hofstra RM; Wu Y; Stulp RP; Elfferich P; Osinga J; Maas SM; Siderius L; Brooks AS; vd Ende JJ; Heydendael VM; Severijnen RS; Bax KM; Meijers C; Buys CH
Hum Mutat; 2000; 15(5):418-29. PubMed ID: 10790203
[TBL] [Abstract][Full Text] [Related]
2. Germline mutations in glial cell line-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient.
Angrist M; Bolk S; Halushka M; Lapchak PA; Chakravarti A
Nat Genet; 1996 Nov; 14(3):341-4. PubMed ID: 8896568
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the RET, GDNF, EDN3, and EDNRB genes in patients with intestinal neuronal dysplasia and Hirschsprung disease.
Gath R; Goessling A; Keller KM; Koletzko S; Coerdt W; Müntefering H; Wirth S; Hofstra RM; Mulligan L; Eng C; von Deimling A
Gut; 2001 May; 48(5):671-5. PubMed ID: 11302967
[TBL] [Abstract][Full Text] [Related]
4. Germline mutations of the RET ligand GDNF are not sufficient to cause Hirschsprung disease.
Salomon R; Attié T; Pelet A; Bidaud C; Eng C; Amiel J; Sarnacki S; Goulet O; Ricour C; Nihoul-Fékété C; Munnich A; Lyonnet S
Nat Genet; 1996 Nov; 14(3):345-7. PubMed ID: 8896569
[TBL] [Abstract][Full Text] [Related]
5. De novo mutation of GDNF, ligand for the RET/GDNFR-alpha receptor complex, in Hirschsprung disease.
Ivanchuk SM; Myers SM; Eng C; Mulligan LM
Hum Mol Genet; 1996 Dec; 5(12):2023-6. PubMed ID: 8968758
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of RET/GDNF/NTN genes in children with total colonic aganglionosis with small bowel involvement.
Inoue K; Shimotake T; Iwai N
Am J Med Genet; 2000 Aug; 93(4):278-84. PubMed ID: 10946353
[TBL] [Abstract][Full Text] [Related]
7. Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease.
Attié T; Pelet A; Edery P; Eng C; Mulligan LM; Amiel J; Boutrand L; Beldjord C; Nihoul-Fékété C; Munnich A
Hum Mol Genet; 1995 Aug; 4(8):1381-6. PubMed ID: 7581377
[TBL] [Abstract][Full Text] [Related]
8. Mutation of the RET ligand, neurturin, supports multigenic inheritance in Hirschsprung disease.
Doray B; Salomon R; Amiel J; Pelet A; Touraine R; Billaud M; Attié T; Bachy B; Munnich A; Lyonnet S
Hum Mol Genet; 1998 Sep; 7(9):1449-52. PubMed ID: 9700200
[TBL] [Abstract][Full Text] [Related]
9. Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease.
Carlomagno F; Melillo RM; Visconti R; Salvatore G; De Vita G; Lupoli G; Yu Y; Jing S; Vecchio G; Fusco A; Santoro M
Endocrinology; 1998 Aug; 139(8):3613-9. PubMed ID: 9681515
[TBL] [Abstract][Full Text] [Related]
10. Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL.
Woodward ER; Eng C; McMahon R; Voutilainen R; Affara NA; Ponder BA; Maher ER
Hum Mol Genet; 1997 Jul; 6(7):1051-6. PubMed ID: 9215674
[TBL] [Abstract][Full Text] [Related]
11. Hirschsprung associated GDNF mutations do not prevent RET activation.
Borghini S; Bocciardi R; Bonardi G; Matera I; Santamaria G; Ravazzolo R; Ceccherini I
Eur J Hum Genet; 2002 Mar; 10(3):183-7. PubMed ID: 11973622
[TBL] [Abstract][Full Text] [Related]
12. [Molecular basis of Hirschsprung disease].
Inoue M; Okada A
Nihon Rinsho; 1998 Jan; 56(1):249-57. PubMed ID: 9465697
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of the ret and GDNF genes in a family with multiple endocrine neoplasia type 2A and Hirschsprung disease.
Borrego S; Eng C; Sánchez B; Sáez ME; Navarro E; Antiñolo G
J Clin Endocrinol Metab; 1998 Sep; 83(9):3361-4. PubMed ID: 9745455
[TBL] [Abstract][Full Text] [Related]
14. Cloning and characterization of the human GFRA2 locus and investigation of the gene in Hirschsprung disease.
Vanhorne JB; Gimm O; Myers SM; Kaushik A; von Deimling A; Eng C; Mulligan LM
Hum Genet; 2001 May; 108(5):409-15. PubMed ID: 11409869
[TBL] [Abstract][Full Text] [Related]
15. Congenital central hypoventilation syndrome: a novel mutation of the RET gene in an isolated case.
Kanai M; Numakura C; Sasaki A; Shirahata E; Akaba K; Hashimoto M; Hasegawa H; Shirasawa S; Hayasaka K
Tohoku J Exp Med; 2002 Apr; 196(4):241-6. PubMed ID: 12086152
[TBL] [Abstract][Full Text] [Related]
16. Familial form of hirschsprung disease: nucleotide sequence studies reveal point mutations in the RET proto-oncogene in two of six families but not in other candidate genes.
Munnes M; Fanaei S; Schmitz B; Muiznieks I; Holschneider AM; Doerfler W
Am J Med Genet; 2000 Sep; 94(1):19-27. PubMed ID: 10982477
[TBL] [Abstract][Full Text] [Related]
17. Japanese patients with sporadic Hirschsprung: mutation analysis of the receptor tyrosine kinase proto-oncogene, endothelin-B receptor, endothelin-3, glial cell line-derived neurotrophic factor and neurturin genes: a comparison with similar studies.
Sakai T; Nirasawa Y; Itoh Y; Wakizaka A
Eur J Pediatr; 2000 Mar; 159(3):160-7. PubMed ID: 10664228
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of mutations in the GDNF gene of patients with Hirschsprung disease.
Eketjäll S; Ibáñez CF
Hum Mol Genet; 2002 Feb; 11(3):325-9. PubMed ID: 11823451
[TBL] [Abstract][Full Text] [Related]
19. Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease.
Angrist M; Bolk S; Thiel B; Puffenberger EG; Hofstra RM; Buys CH; Cass DT; Chakravarti A
Hum Mol Genet; 1995 May; 4(5):821-30. PubMed ID: 7633441
[TBL] [Abstract][Full Text] [Related]
20. Two distinct mutations of the RET receptor causing Hirschsprung's disease impair the binding of signalling effectors to a multifunctional docking site.
Geneste O; Bidaud C; De Vita G; Hofstra RM; Tartare-Deckert S; Buys CH; Lenoir GM; Santoro M; Billaud M
Hum Mol Genet; 1999 Oct; 8(11):1989-99. PubMed ID: 10484767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
